In the face of shifting consumer health trends, Novo’s online direct-to-patient pharmacy NovoCare has adapted in turn with a ...
In a complete response letter (PDF) dated Nov. 13 and newly published on the FDA’s website, reviewers at the agency flagged ...
The White House is reportedly pulling the nomination for Heidi Overton, M.D., Ph.D., to lead the FDA just hours before the ...
On a hot streak, GSK has won a third high-profile FDA approval in recent weeks, this time for the second lung cancer drug ...
No breast cancer asset in Roche’s pipeline carries a higher valuation than giredestrant. | Roche’s giredestrant took the ...
Winning a ruling in their favor Monday, AstraZeneca and its rare disease unit Alexion have successfully sidestepped U.S.
AriBio’s erectile dysfunction med-turned Alzheimer’s disease candidate mirodenafil has delivered some mixed results from a ...
BeOne Medicines has expanded its partnership with CLL Society, entering into a three-year, $3 million pact to support ...
Novartis is eking out the life of its aging immunology med, Cosentyx, with another label expansion. | Cosentyx's latest FDA ...
Another pharma is revving into the auto racing zone, this time with Viatris pulling up as the Cadillac Formula 1 team’s ...
The observations largely centered on a lack of procedures that could lead to microbial and particulate contamination.
Leo Pharma appears to be second guessing its plans for a 2026 initial public offering.   | Ownership behind Danish ...